Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers

NCT05296083 is registered in ClinicalTrials.gov with SQ Innovation, Inc. as lead sponsor.

NCT NCT05296083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05296083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers
Lead sponsor
SQ Innovation, Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 17, 2022
Completion date
May 25, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal discomfort, performance status